Raymond James & Associates’s XPeng XPEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,878
Closed -$173K 4054
2023
Q4
$173K Sell
11,878
-1,312
-10% -$20.9K ﹤0.01% 3550
2023
Q3
$242K Buy
+13,190
New +$224K ﹤0.01% 3356
2022
Q3
Sell
-6,986
Closed -$222K 4156
2022
Q2
$222K Sell
6,986
-1,368
-16% -$35.2K ﹤0.01% 3437
2022
Q1
$230K Buy
8,354
+372
+5% +$13.2K ﹤0.01% 3588
2021
Q4
$402K Buy
7,982
+1,440
+22% +$64.9K ﹤0.01% 3251
2021
Q3
$233K Buy
6,542
+550
+9% +$21.8K ﹤0.01% 3584
2021
Q2
$266K Sell
5,992
-2,323
-28% -$79.2K ﹤0.01% 3517
2021
Q1
$304K Buy
+8,315
New +$346K ﹤0.01% 3352

Other funds holding XPEV

Raymond James & Associates's XPEV Position: Q1 2024 in Review

Raymond James & Associates sold out of XPeng (XPEV) in Q1 2024, closing a stake of 11,878 shares — an estimated $173K sold.

Raymond James & Associates first reported a position in XPEV in Q1 2021 and held it in 8 quarters. The position peaked at $402K in Q4 2021. 195 funds tracked by Wall St. Rank hold XPEV as of Q1 2024.

  • Raymond James & Associates reported no remaining XPeng position as of Q1 2024 after selling out during the quarter.
  • Raymond James & Associates sold 11,878 XPeng shares in Q1 2024, an estimated $173K.
  • Raymond James & Associates first reported a position in XPeng in Q1 2021 and held it in 8 quarters.
  • Raymond James & Associates's XPeng position peaked at $402K in Q4 2021.
  • 195 funds tracked by Wall St. Rank held XPeng as of Q1 2024.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.